Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Scientific Reports|February 11, 2025
The protective effect of sodium-glucose cotransporter-2 inhibitor on left ventricular global longitudinal strain in patients with type 2 diabetes mellitus according to disease durationZiying Wang, Long Huang, Leilei Han, et al.
Frontiers in Endocrinology|February 12, 2026
TyG index and MAFLD severity are associated with subclinical LV dysfunction in T2DM patients: a cross-sectional studyXiangsui Hu, Hanwei Chen, Ziying Wang, et al.
Journal of Nanobiotechnology|December 17, 2023
Natural ursolic acid based self-therapeutic polymer as nanocarrier to deliver natural resveratrol for natural therapy of acute kidney injuryYuanpeng Nie, Liying Wang, Shengbo Liu, et al.
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|May 16, 2025
IL-35 Ameliorates Myocardial Strain in Mice with T2DM-Induced Cardiac Injury: Assessment by Layer-Specific StrainZiying Wang, Leilei Han, Mingyi Dong, et al.
JAMA Network Open|July 11, 2019
Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level AnalysisYunfang Yu, Dongqiang Zeng, Qiyun Ou, et al.
ACS Applied Materials & Interfaces|April 28, 2021
A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor TherapyWantao Tang, Lin Han, Xuehe Lu, et al.
Journal of Cancer Research and Clinical Oncology|September 1, 2023
Radiation-sensitive genetic prognostic model identifies individuals at risk for radiation resistance in head and neck squamous cell carcinomaPeimeng You, Shengbo Liu, Qiaxuan Li, et al.
International Journal of Food Sciences and Nutrition|June 4, 2019
Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycleHui-Zhi Yang, Jiaojiao Zhang, Jie Zeng, et al.
Journal of Thoracic Disease|January 7, 2022
Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): a study protocol of prospective, single-arm, multicenter, phase II studyHaiyu Zhou, Lili Lin, Tao Qin, et al.
Theranostics|August 4, 2025
NIR-II light-driven <i>in situ</i> nanovaccine for cancer immunotherapy via lymph node migration-mediated accumulationYucheng Huang, Miao Su, Weihuan Lin, et al.
Pageof 4